DK1078063T3 - BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis - Google Patents
BASB029-polynukleotider og -polypeptider fra Neisseria meningitidisInfo
- Publication number
- DK1078063T3 DK1078063T3 DK99924946T DK99924946T DK1078063T3 DK 1078063 T3 DK1078063 T3 DK 1078063T3 DK 99924946 T DK99924946 T DK 99924946T DK 99924946 T DK99924946 T DK 99924946T DK 1078063 T3 DK1078063 T3 DK 1078063T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptides
- neisseria meningitidis
- basb029
- polynucleotides
- basb029 polynucleotides
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000040430 polynucleotide Human genes 0.000 title abstract 2
- 108091033319 polynucleotide Proteins 0.000 title abstract 2
- 239000002157 polynucleotide Substances 0.000 title abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810276.7A GB9810276D0 (en) | 1998-05-13 | 1998-05-13 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1078063T3 true DK1078063T3 (da) | 2006-04-03 |
Family
ID=10831992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99924946T DK1078063T3 (da) | 1998-05-13 | 1999-05-07 | BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US6780419B1 (enExample) |
| EP (2) | EP1621623A3 (enExample) |
| JP (2) | JP4707832B2 (enExample) |
| KR (4) | KR100673674B1 (enExample) |
| CN (1) | CN1322127C (enExample) |
| AT (1) | ATE311457T1 (enExample) |
| AU (1) | AU750032B2 (enExample) |
| BR (1) | BR9910396A (enExample) |
| CA (1) | CA2328403C (enExample) |
| CY (1) | CY1105676T1 (enExample) |
| CZ (1) | CZ299612B6 (enExample) |
| DE (1) | DE69928658T2 (enExample) |
| DK (1) | DK1078063T3 (enExample) |
| ES (1) | ES2252946T3 (enExample) |
| GB (1) | GB9810276D0 (enExample) |
| HU (1) | HUP0102479A3 (enExample) |
| IL (2) | IL139613A0 (enExample) |
| NO (2) | NO326994B1 (enExample) |
| NZ (1) | NZ508323A (enExample) |
| PL (1) | PL197449B1 (enExample) |
| TR (1) | TR200003347T2 (enExample) |
| WO (1) | WO1999058683A2 (enExample) |
| ZA (1) | ZA200006523B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| DE69941567D1 (de) * | 1998-01-14 | 2009-12-03 | Novartis Vaccines & Diagnostic | Antigene aus neisseria meningitidis |
| GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
| PT1154790E (pt) | 1999-02-26 | 2005-03-31 | Chiron Srl | Reforco da actividade bactericida de antigenios contra a neisseria com oligonucleotidos contendo motivos cg |
| GB9916529D0 (en) * | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
| PT2275554E (pt) | 1999-10-29 | 2015-06-26 | Novartis Vaccines & Diagnostic | Péptidos antigénicos de neisseria |
| GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| EP2275129A3 (en) | 2000-01-17 | 2013-11-06 | Novartis Vaccines and Diagnostics S.r.l. | Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins |
| BR0107857A (pt) * | 2000-01-25 | 2002-10-29 | Univ Queensland | Proteìnas compreendendo regiões conservadas de antìgeno nhha de superfìcie de neisseria meningitidis |
| PT1790660E (pt) | 2000-02-28 | 2012-09-17 | Novartis Vaccines & Diagnostic | Expressão heteróloga de proteínas de neisseria |
| EP1412381B1 (en) | 2001-07-27 | 2010-06-02 | Novartis Vaccines and Diagnostics S.r.l. | Antibodies against meningococcal adhesin app |
| WO2004014417A2 (en) * | 2002-08-02 | 2004-02-19 | Glaxosmithkline Biologicals Sa | Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| SI2353608T1 (sl) | 2002-10-11 | 2020-12-31 | Glaxosmithkline Biologicals Sa | Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam |
| CA2540896C (en) | 2003-10-02 | 2015-06-02 | Chiron Srl | Liquid vaccines for multiple meningococcal serogroups |
| US7459930B2 (en) * | 2006-11-14 | 2008-12-02 | Micron Technology, Inc. | Digital calibration circuits, devices and systems including same, and methods of operation |
| GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
| GB0916570D0 (en) | 2009-09-21 | 2009-10-28 | Royal Holloway & Bedford New C | Method |
| BR112012022800A2 (pt) | 2010-03-11 | 2018-05-15 | Glaxosmithkline Biologicals Sa | composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica |
| US10161940B2 (en) * | 2012-01-05 | 2018-12-25 | Deutsches Krebsforschungszentrum | Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers |
| ES2801054T3 (es) | 2016-07-27 | 2021-01-08 | Prysmian Spa | Cinta de fibra óptica flexible |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4769240A (en) * | 1980-09-15 | 1988-09-06 | Bactex, Inc. | Pili of neisseria and vaccine compositions containing same |
| US4702911A (en) * | 1985-09-27 | 1987-10-27 | Immunomed Corporation | Preparation of bacterium pili subunits and vaccines containing pili subunits |
| JPH01125328A (ja) * | 1987-07-30 | 1989-05-17 | Centro Natl De Biopreparados | 髄膜炎菌ワクチン |
| FR2682041B1 (fr) * | 1991-10-03 | 1994-01-14 | Pasteur Merieux Serums Vaccins | Vaccin contre les infections a neisseria meningitidis. |
| US6245337B1 (en) * | 1994-08-25 | 2001-06-12 | Washington University | Haemophilus adherence and penetration proteins |
| US6121037A (en) * | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
| US5646259A (en) * | 1995-03-24 | 1997-07-08 | St. Louis University | DNA encoding haemophilus adhesion proteins |
| US6265567B1 (en) * | 1995-04-07 | 2001-07-24 | University Of North Carolina At Chapel Hill | Isolated FrpB nucleic acid molecule |
| CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| DE69941567D1 (de) * | 1998-01-14 | 2009-12-03 | Novartis Vaccines & Diagnostic | Antigene aus neisseria meningitidis |
| GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
| US7368261B1 (en) * | 1999-04-30 | 2008-05-06 | Novartis Vaccines And Diagnostics Srl | Conserved Neisserial antigens |
-
1998
- 1998-05-13 GB GBGB9810276.7A patent/GB9810276D0/en not_active Ceased
-
1999
- 1999-05-07 NZ NZ508323A patent/NZ508323A/xx not_active IP Right Cessation
- 1999-05-07 CZ CZ20004202A patent/CZ299612B6/cs not_active IP Right Cessation
- 1999-05-07 DK DK99924946T patent/DK1078063T3/da active
- 1999-05-07 CN CNB998086061A patent/CN1322127C/zh not_active Expired - Fee Related
- 1999-05-07 EP EP20050077297 patent/EP1621623A3/en not_active Withdrawn
- 1999-05-07 AU AU41420/99A patent/AU750032B2/en not_active Ceased
- 1999-05-07 IL IL13961399A patent/IL139613A0/xx unknown
- 1999-05-07 CA CA2328403A patent/CA2328403C/en not_active Expired - Fee Related
- 1999-05-07 DE DE69928658T patent/DE69928658T2/de not_active Expired - Lifetime
- 1999-05-07 US US09/700,293 patent/US6780419B1/en not_active Expired - Lifetime
- 1999-05-07 JP JP2000548474A patent/JP4707832B2/ja not_active Expired - Fee Related
- 1999-05-07 KR KR1020007012700A patent/KR100673674B1/ko not_active Expired - Fee Related
- 1999-05-07 KR KR1020097024661A patent/KR20100019461A/ko not_active Ceased
- 1999-05-07 PL PL345281A patent/PL197449B1/pl not_active IP Right Cessation
- 1999-05-07 HU HU0102479A patent/HUP0102479A3/hu unknown
- 1999-05-07 BR BR9910396-6A patent/BR9910396A/pt not_active Application Discontinuation
- 1999-05-07 KR KR1020067009829A patent/KR100897951B1/ko not_active Expired - Fee Related
- 1999-05-07 WO PCT/EP1999/003255 patent/WO1999058683A2/en not_active Ceased
- 1999-05-07 EP EP99924946A patent/EP1078063B1/en not_active Expired - Lifetime
- 1999-05-07 AT AT99924946T patent/ATE311457T1/de active
- 1999-05-07 ES ES99924946T patent/ES2252946T3/es not_active Expired - Lifetime
- 1999-05-07 TR TR2000/03347T patent/TR200003347T2/xx unknown
- 1999-05-07 KR KR1020087014761A patent/KR20080070073A/ko not_active Ceased
-
2000
- 2000-11-10 IL IL139613A patent/IL139613A/en not_active IP Right Cessation
- 2000-11-10 ZA ZA200006523A patent/ZA200006523B/xx unknown
- 2000-11-10 NO NO20005696A patent/NO326994B1/no not_active IP Right Cessation
-
2004
- 2004-07-22 US US10/896,778 patent/US20040265332A1/en not_active Abandoned
-
2006
- 2006-01-17 CY CY20061100057T patent/CY1105676T1/el unknown
-
2007
- 2007-12-07 US US11/999,978 patent/US20090093622A1/en not_active Abandoned
-
2009
- 2009-03-02 NO NO20090955A patent/NO20090955L/no not_active Application Discontinuation
-
2010
- 2010-03-01 JP JP2010044336A patent/JP2010166921A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1078063T3 (da) | BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis | |
| GB9811260D0 (en) | Novel compounds | |
| PT1112366E (pt) | Polinucleotideos e polipeptideos basb033 da neisseria meningitidis e suas utilizacoes | |
| CY1108280T1 (el) | Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν | |
| DK1163343T3 (da) | Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer | |
| GB9809683D0 (en) | Novel compounds | |
| WO2000043519A3 (en) | Neisseria meningitidis polypeptides | |
| GB9810285D0 (en) | Novel compounds | |
| GB9812440D0 (en) | Novel compounds | |
| GB9812163D0 (en) | Novel compounds | |
| ATE527360T1 (de) | Neue verbindungen abgeleitet von neisseria meningitidis | |
| GB0025170D0 (en) | Novel compounds | |
| HK1042924A1 (zh) | 從淋球性腦膜炎獲得的basb059多肽 | |
| GB0025169D0 (en) | Novel compounds |